loading...| Preferred Name |
Pegvisomant |
|
| Synonyms |
|
|
| ID |
http://www.phoc.org.cn/pmo/class/PMO_00025939 |
|
| Database_Cross_Reference |
SNOMEDCT_US:409204008 MMSL:d04854 MTH:NOCODE ATC:H01AX01 RXNORM:278739 MEDCIN:258285 SNOMEDCT_US:409201000 NDFRT:N0000010158 NCI:C61881 MSH:C406545 VANDF:4021390 SNOMEDCT_US:398875005 MMSL:17174 NCI_DCP:50484 NCI_FDA:N824AOU5XV DRUGBANK:DB00082 NDFRT:N0000148808 NDDF:009929 MTHSPL:N824AOU5XV USPMG:MTHU001417 |
|
| label |
Pegvisomant |
|
| MCID |
MC00319988 |
|
| PMOID |
PMO:00025939 |
|
| prefixIRI |
pmo:PMO_00025939 |
|
| prefLabel |
Pegvisomant |
|
| Synonym |
GH-N Pegvisomant (product) Somatotropin (18-Aspartic Acid, 21-Asparagine, 120-Lysine, 167-Asparagine, 168-Alanine, 171-Serine, 172-Arginine, 174-Serine, 179-Threonine) (Human), Pegylated Growth hormone Pituitary growth hormone PEGVISOMANT pegvisomant pegvisomant (medication) Somatotropin precursor Growth hormone 1 pegvisomant [Chemical/Ingredient] GH Pegvisomant (substance) growth hormone receptor antagonists pegvisomant |
|
| Tree Number |
T6.4.5.1.3.1.1 |
|
| subClassOf |